Investor Relations

everything you need to make informed investment decisions

recent releases
View all
Sep 15, 2022
Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advancements in Producing PHA Bioplastic in Camelina at the ISBP 2022 Conference

Press release

WOBURN, Mass. , Sept. 15, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that its Chief Science Officer Dr. Kristi Snell will present during the International Symposium on Biopolymers (“ISBP”) 2022

events & presentations
View all
Sep 16, 2022
ISBP 2022 Conference
Sep 14, 2022
Investor Presentation
Sep 13, 2022 2:00 PM EDT
H.C. Wainwright 24th Annual Global Investment Conference
recent sec filings
View all
 
D
external link icon
D
external link icon

A preliminary proxy statement providing notification matters to be brought to a vote

external link icon

A preliminary proxy statement providing notification matters to be brought to a vote

external link icon